Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands. ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases. ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Jacob Siebert, Partner, Co-Lead Dr Dirk Baukholt, Principal Counsel Dr Berrit Roth-Mingram, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Roland Wiring, Partner Lukas Burgdorff, Associate Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Dr Michael Bauer, Partner Stefan Lehr, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel Dr. Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Dr Thomas de la Motte, Partner Dr Markus Pfaff, Partner Dr André Frischemeier, Partner Hatice Aykel, Counsel Alisa Brehm, Senior Associate Thomas Schaak, Senior Associate Dr Sait Dogan, Associate, all Banking & Finance  Dr André Lippert, Part­ner Con­stan­ze Schweidtmann, Associate, both Real Estate & Public Dr Boris Alles, Partner Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions CMS France Benoît Gomel, Partner Vincent Desbenoit, Associate Dylan Allali, all Corporate/M&A Caroline Froger-Michon, Partner Aurélie Parchet, As­so­ci­ate Ca­m­ille Baumgarten, Associate Sophie Yin, all Em­ploy­ment Claire Vannini, Partner Eleni Moraïtou, Coun­sel Lilia-Ori­ana Dif, Associate Ariane Rolin, all Competition & EU  Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, Associate, both Intellectual Property Laurine Mayer, Associate, TMC Alexandre Chazot, Counsel, Banking & Fin­ance  Thi­erry Granier, Partner Renaud Grob, Partner, both Tax Arnaud Valverde, Senior Associate, Real Estate Olivier Kuhn, Partner Cécile Rebiffé, Counsel Mylène Garrouste, all Dispute Res­ol­u­tion Kawthar Ben Khelil, Coun­sel Jean-Pierre Malili, Associate, both Public law/In­fra­struc­ture CMS Italy Massimo Trentino, Partner, Corporate/M&A Maria Letizia Patania, Partner, Lifescience & Healthcare Gian Marco Lettieri, Senior Associate, Employment & Pensions Giulio Poggioli, Counsel Valerio Giuseppe Daniele, As­so­ci­ate Francesca Durante, Junior As­so­ci­ate  Arianna Toccaceli, Junior Associate, all Banking & Finance CMS Luxembourg Gérard Maitrejean, Partner Miruna Poenaru, Coun­sel Max­imili­an Helfgen, Associate, all Corporate/M&A CMS UK Jack Letson, Partner Lindsay McAllister, Associate, both Corporate/M&A David Dennis, Partner, Commercial CMS Netherlands Pieter van Duijvenvoorde, Partner Robert Jong, both Corporate/M&A Nigel Henssen Fleur van Assendelft de Coningh, both Employment Edmon Oude Elferink, Partner Marijke van der Vossen, both Antitrust, Competition & Trade CMS Serbia Radivoje Petrikić, Partner Mila Drljević, both Corporate/M&A CMS Austria Dieter Zandler, Partner Vanessa Horaceck, both Competition & EU CMS Ukraine Maria Orlyk, Partner Diana Valyeyeva CMS Turkiye Döne Yalçın, Partner Arcan Kemahlı,  Sa­ba­hat­tin Öztemiz Taner ElmasPress Con­tact presse@cms-hs. com

Frankfurt/Main – The HIMA Group, based in Brühl in Baden-Württem­berg, one of the leading providers of safety-related automation solutions for the process and rail industry, has acquired Origo Solutions AS. The Norwegian target company is recognized as a market leader in safety, automation and instrumentation systems for monitoring, control and protection of offshore and onshore installations in Norway and internationally for complete SCADA systems for the renewable energy sector. The technology company has more than 40 years’ of experience. For more than 20 years, Origo Solutions has been HIMA's exclusive representative in Norway. With this transaction, both companies intend to continue their growth strategies and expand their range of solutions for the process industry and renewable energies. Main focus here is the digitalisation of functional safety. For HIMA, the acquisition is another important step in the strategic development of the HIMA Group following the expansion in the UK, which was completed in 2023. Origo Solutions was previously owned by Moreld AS (60,1 %) and Aker Capital AS (39,9 %) and a part of the Moreld Group, a leading industrial multi-dis­cip­lin­ary engineering group in Norway. The agreement was signed on 8 January and is effective as of 31 January. The parties involved have agreed not to disclose further details of the transaction.A cross-border CMS team from Germany and Norway headed by lead partner Dr Hendrik Hirsch and Lead Counsel Dr Berrit Roth-Mingram advised HIMA on all legal aspects of the acquisition. Dr Hendrik Hirsch is the Client Relationship Partner for HIMA. The safety specialist regularly relies on the expertise of CMS, most recently on the acquisition of the British system integrator Sella Controls. Press Con­tact presse@cms-hs. com

Frankfurt/Main – F24 Nordics AS, a Scandinavian unit of the F24 Group, has acquired Blue Idea ApS, a leading SaaS provider for service messaging in the Nordic countries. The F24 Group is a leader in...

Stuttgart - An international team led by CMS partner Dr. Tobias Grau advised founder Thomas Schwanhäuser on the sale of all shares in Solvians Group to Bowmark Capital LLP, a London-based private equity...

Hamburg – Warburg Bank has sold all the shares in Warburg Invest AG to Bantleon AG as part of adopting a more focused strategy on institutional asset management. Warburg Invest AG is a German investment...

Frankfurt/Main – Bruker Corporation, a NASDAQ-listed US tech company, has entered into a partnership with Swiss firm Biognosys AG to deliver advanced proteomics CRO services for US biopharma and biomarker...

Frankfurt/Main – The shareholders of M.M. Warburg & CO Hypothekenbank AG, namely M.M. Warburg & CO (AG & Co.) KGaA (60%) and Landeskranken­hil­fe V.V.a.G. (40%), have sold all their shares in Warburg...